Details checkedClinical trial listing onlyHistorical/discontinuedCheckedregistry

Assiut systemic/intratympanic steroid SSNHL study

Also known as: Systemic and intratympanic injection of steroid, Predictive factors in ISSNHL, NCT05112354

Institution-led study

Primary source

Sponsor / Institution

Institution-led study

Program Type

Therapeutic

Modality

Steroid/Anti-inflammatory

Stage

Phase 2

Status

Completed

Target Gene

—

Route / Mode

Systemic oral corticosteroid and intratympanic steroid injection

Confidence

82%

Status Confidence

Status needs checking

Evidence Strength

Needs more support

Last Reviewed

2026-06-10

Geography

Egypt

Population

pediatric, adult, sudden, sensorineural, tinnitus, vertigo

Trial IDs

Mechanism

Completed Assiut University study evaluating predictive factors for recovery under standardized SSNHL management that included systemic oral corticosteroids, intratympanic steroid after systemic failure or delayed presentation, antiviral therapy, and vasodilator therapy.

Indications

Hearing Loss Sensorineural Hearing Loss Sudden Sensorineural Hearing Loss Tinnitus

Notes

Corrected spelling and normalized as a completed institution-led SSNHL management/prognostic study. This is not a distinct commercial steroid product.

Evidence & Sources

1 structured sources

clinicaltrials

Supports: canonicalName, aliases, allCompanies, isIndustrySponsored, stage, status, route, indications...

IDs: NCT05112354

Open

Key Events

2019-12-01

Assiut ISSNHL predictive-factors study started

2021-06-30

Registry lists study completion date

Clinical Trials (1)